Live from the NIH registry
Studies recruiting near Long Beach right now
Top 25 of 3,348 recruiting studies, sorted by proximity — each links to its official registry page
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
The Regents of the University of California, Los Angeles — Los Angeles, California (18.1 mi)
· Sponsor: University of Pittsburgh
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
UCLA Care — Los Angeles, California (18.1 mi)
· Sponsor: Westat
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (18.1 mi)
· Sponsor: Relay Therapeutics, Inc.
Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)
Actinic Keratosis (AK)
N/A
Observational 30 participants sought
Ablon Skin Institute and Research Center — Manhattan Beach, California (15.2 mi)
· Sponsor: Avant Health LLC
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Miller Children's and Women's Hospital Long Beach — Long Beach, California (2.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Clinical Research Institute, LCC — Los Angeles, California (18.1 mi)
· Sponsor: AbbVie
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
Marvel Clinical Research — Huntington Beach, California (13.5 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (13.7 mi)
· Sponsor: Takeda
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Macula Retina Vitreous Research Institute — Torrance, California (10.3 mi)
· Sponsor: Genentech, Inc.
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
Postpartum Hypertension (PPHT)
Phase 4
Interventional 110 participants sought
UCLA Ronald Reagan — Los Angeles, California (18.1 mi)
· Sponsor: University of California, Los Angeles
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
Children With Medical Complexity (CMC), Multiple Chronic Conditions
N/A
Interventional 110 participants sought
Children's Hospital Los Angeles — Los Angeles, California (18.1 mi)
· Sponsor: University of Utah
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Local Institution - 0082 — Long Beach, California (2.5 mi)
· Sponsor: Mirati Therapeutics Inc.
Housing Transitions QUERI
Homelessness
Phase 1
Interventional 153 participants sought
VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California (22.9 mi)
· Sponsor: VA Office of Research and Development
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
Advanced Cancer, Solid Tumor
Phase 1
Interventional 26 participants sought
City of Hope National Medical Center — Duarte, California (26.0 mi)
· Sponsor: Proviva Therapeutics, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Irvine, California (21.7 mi)
· Sponsor: AstraZeneca
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (24.1 mi)
· Sponsor: Astellas Pharma Inc
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Multiple conditions
N/A
Observational 4,000 participants sought
Congenital Muscle Disease International Registry (www.cmdir.org) — Lakewood, California (4.3 mi)
· Sponsor: Cure CMD
Automated Insulin for Management of Intrapartum Glycemia
Type 1 Diabetes (T1D), Pregnancy
N/A
Interventional 150 participants sought
University of California, Los Angeles — Los Angeles, California (18.1 mi)
· Sponsor: University of California, San Francisco
YAG Laser Vitreolysis for Vitreous Floaters
Posterior Vitreous Detachment, Myopic Vitreopathy
N/A
Interventional 50 participants sought
VMR Institute for Vitreous Macula Retina — Huntington Beach, California (13.5 mi)
· Sponsor: VMR Consulting, Inc.
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Santa Ana, California (17.6 mi)
· Sponsor: Axsome Therapeutics, Inc.
Effect of Electro-Acupuncture on Blood Pressure
Hypertension
N/A
Interventional 160 participants sought
UCIMedical Center — Orange, California (18.0 mi)
· Sponsor: University of California, Irvine
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Glioblastoma Multiforme
Phase 1, Phase 2
Interventional 10 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (18.1 mi)
· Sponsor: Chirag G. Patil
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
University of California - Irvine — Irvine, California (21.7 mi)
· Sponsor: AskBio Inc
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
University of California Irvine — Orange, California (18.0 mi)
· Sponsor: Regeneron Pharmaceuticals
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Southern California — Los Angeles, California (18.1 mi)
· Sponsor: AB Science